Market Ready

The company has a myriad of drugs ready for market deployment with Chinese FDA approval. The following table outlines the product inventory

Gatifloxacin Lactate Injection

Indications of the two types of drugs are as follows: acute nasosinusitis caused by the treatment of sensitive bacteria, acute outbreaks of the chronic bronchitis, pneumonia attained in a community, simple or complex cystitis, nephritis of renal pelvis, simple urethra and cervix gonorrhea, acute simple-natured rectal infection of women

Calcium Dibutyryl Adenosine Monophosphate for Injection

This medicine is for the treatment of angina and acute myocardial infarction. It is a ramification of the chemosuythesized dibutyryl adenosine and a type of activator on albumen. Its osmosis is stronger than that of dibutyryl adenosine and it is able to confront the reducing and dispelling effects of PDE. So it has a fast and enduring effect on reducing the oxygen shortage of cardiac muscles, dilating coronary artery, boost up the contractibility of cardiac muscles and increasing the flowage of blood from the heart.

Nicergoline for Infection (spec: 4mg)

Used for the treatment of poor conation and sensibility obstacles caused by naogengse sequela, such as hypoesthesia, poor concentration, memory recession, idea shortage and anxiety. It is a ramification of the half- synthetically ergot and can blocks the receptors and dilate bloods vessels. Therefore, it is able to strengthen the metabolism of brain cells and make better use of oxygen and dextrose, thus improve the working of the brain.

Soduim Aescinate for Injection (spec: 5mg, 10mg)

This medicine is used for used for the treatment of hydrocephalus caused by different diseases, tumefaction arising of wounds and operations, as well as circumfluence expediency of the vein. As a type of anti-tumefaction and inflammation-diminishing drug, it has effects such as anti-effusion, increasing vein tensility, anti-tumefaction, anti- inflammation, and improving blood circulation.

Rabeprazole Sodium, Rabeprazole Sodium Entericoated Tablet (spec: 10mg)

This medicine is used for the treated of gastric ulcer, duodenum ulcer, anastomosis ulcer, anti-flow of esophagus inflammation, Zollinger- Ellison syndrome.

Compound Allantoin Dispersible Tablets (spec: 12pill/plate)

It is used for the treatment of gastric ulcer, ulcer of the ball part of the duodenum and chronic gastritis.

Candesartan Pills (spec: 8mg)

It is used for the treatment of primary hypertension of light and medium levels. As AT1 CB of Angell receptors, it works through selectively blocking the combination between Angell, adrenal gland and vascular uterine cells thus restraining the shrinkage of blood vessels and excretion of aldosterone to reduce the blood pressure. (It is a patented product of our Company.)

Nicergoline Pills (spec: 10mg)

It is used for the treatment of poor conation and sensibility obstacles caused by naogenges sequela, such as hypoesthesia, poor concentration, memory recession, idea shortage and anxiety. It is a ramification of the half-synthetically ergot and can block the receptors and dilate blood vessels. Therefore, it is able to strengthen the metabolism of brain cells and make better use of oxygen and dextrose, thus improve the working of the brain. (It is a patented product of our Company.)

Rabeprazole Sodium Pills (spec: 10mg)

This medicine is used for the treatment of gastric ulcer, duodenum ulcer, anastomosis ulcer, anti-flow of esophagus inflammation, Zollinger-Ellison syndrome.

This website contains forward-looking statements that involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the company's limited operating history, the limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the company's business and financial results is included in the Company's filings, available via the United States Securities & Exchange Commission. Occasionally, the Company may select and post articles or opinions of third parties, with no known connection with the Company. These are considered expert or qualified writers about the Chinese economy and its various opportunities and pitfalls. The Company neither endorses nor rejects these views or content, and the articles are offered only for the readers' edification and personal analyses.